The connection between the GM and AD involves a range of pathological mechanisms, including deposition of amyloid-β, hyperphosphorylation of tau, neuroinflammation, mitochondrial dysfunction, and metabolic alterations (Wang et al., 2016; Leblhuber et al., 2021; Chandra et al., 2023). Here, MAPT is linked to Alzheimer disease.